Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Elife|December 23, 2021
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarraysKonrad H Stopsack, Svitlana Tyekucheva, Molin Wang, et al.
Cancer Research|June 22, 2016
Cholesterol Metabolism and Prostate Cancer LethalityKonrad H Stopsack, Travis A Gerke, Jennifer A Sinnott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2017
Perineural Invasion and Risk of Lethal Prostate CancerPiotr Zareba, Richard Flavin, Masis Isikbay, et al.
Molecular Oncology|November 18, 2021
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivityYing Z Mazzu, YuRou Liao, Subhiksha Nandakumar, et al.
Oncogene|November 21, 2021
Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancerYing Z Mazzu, Yu-Rou Liao, Subhiksha Nandakumar, et al.
The Journal of Urology|May 21, 2019
African American Specific Gene Panel Predictive of Poor Prostate Cancer OutcomeMichelle I Echevarria, Shivanshu Awasthi, Chia-Ho Cheng, et al.
The Journal of Clinical Investigation|June 5, 2018
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5DKazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate CancerEmma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
Thyroid : Official Journal of the American Thyroid Association|July 22, 2020
Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS MutationsJuan C Hernandez-Prera, Pablo Valderrabano, Jordan H Creed, et al.
Pageof 4